HUMA
Humacyte Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.16
+0.02 ▲ +1.75%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$1.18
+0.02 ▲ +1.72%
| Index | RUT | P/E | - | EPS (ttm) | -0.24 | Insider Own | 15.05% | Shs Outstand | 0.19B | Perf Week | 4.5% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | -52.21% | Insider Trans | - | Shs Float | 0.16B | Perf Month | 14.85% |
| Enterprise Value | 0.25B | PEG | - | EPS next Q | -0.13 | Inst Own | 28.77% | Short Float | 23.28% | Perf Quarter | -8.66% |
| Income | -0.04B | P/S | 142.6 | EPS this Y | 76.74% | Inst Trans | 6.11% | Short Ratio | 7.12 | Perf Half Y | -22.67% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 51.26% | ROA | -38.15% | Short Interest | 38.16M | Perf YTD | 20.77% |
| Book/sh | -0.03 | P/C | 11.4 | EPS past 3/5Y | -23.74% 42.43% | ROE | -257.38% | 52W High | -65.48% ($3.36) | Perf Year | -58.12% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | -98.17% | 52W Low | 31.82% ($0.88) | Perf 3Y | -56.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 82.23% | Gross Margin | -408.27% | Volatility(W/M) | 8.06% 7.93% | Perf 5Y | -89.78% |
| Dividend TTM | - | EV/Sales | 162.31 | Sales Y/Y TTM | - | Oper. Margin | -6708.4% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.9 | EPS Q/Q | 66.31% | Profit Margin | -2504.33% | RSI (14) | 52.61 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.62 | Sales Q/Q | - | SMA20 | 2% ($1.14) | Beta | 1.89 | Target Price | $8.42 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | 6.83% ($1.09) | Rel Volume | 0.43 | Prev Close | $1.14 |
| Employees | 220 | LT Debt/Eq | - | EPS/Sales Surpr. | 27.15% -18.4% | SMA200 | -28.72% ($1.63) | Avg Volume(3M) | 5.36M | Price | $1.16 |
| IPO | 2020/12/1 | Option/Short | Yes/Yes | Trades | 5158 | Volume | 2,289,297 | Change | 1.75% |
뉴스 로딩 중...